Status:
RECRUITING
A Cohort for Inflammatory Respiratory Diseases: From Phenotyping to Personalised Medicine
Lead Sponsor:
CHU de Reims
Conditions:
Chronic Obstructive Pulmonary Disease
Asthma
Eligibility:
All Genders
18+ years
Brief Summary
Chronic inflammatory pulmonary diseases, including asthma, chronic obstructive pulmonary disease (COPD), bronchiectasis, cystic fibrosis (CF), primary ciliary dyskinesia (PCD) and interstitial lung di...
Detailed Description
The cohort for inflammatory respiratory diseases: from phenotyping to personalised medicine (The PALMIRE project) is a monocentric study conducted at the University Hospital of Reims, France. Study P...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Follow-up for one of the following conditions: asthma, COPD, bronchiectasis (DDB), cystic fibrosis (CF), primary ciliary dyskinesia (PCD), or interstitial lung diseases (ILD)
- Healthy volunteers (controls)
Exclusion
- Subjects protected by law (e.g., legal incapacity)
- Any condition preventing informed consent or participation
Key Trial Info
Start Date :
September 15 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 15 2040
Estimated Enrollment :
470 Patients enrolled
Trial Details
Trial ID
NCT07274631
Start Date
September 15 2025
End Date
September 15 2040
Last Update
February 20 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Reims
Reims, France, 51092